Application Nr Approved Date Route Status External Links
ANDA204762 None Intravenous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Dantrolene Sodium For Injection Is Indicated, Along With Appropriate Supportive Measures, For The Management Of The Fulminant Hypermetabolism Of Skeletal Muscle Characteristic Of Malignant Hyperthermia Crises In Patients Of All Ages. Dantrolene Sodium For Injection Should Be Administered By Continuous Rapid Intravenous Push As Soon As The Malignant Hyperthermia Reaction Is Recognized (I.e., Tachycardia, Tachypnea, Central Venous Desaturation, Hypercarbia, Metabolic Acidosis, Skeletal Muscle Rigidity, Increased Utilization Of Anesthesia Circuit Carbon Dioxide Absorber, Cyanosis And Mottling Of The Skin, And, In Many Cases, Fever). Dantrolene Sodium For Injection Is Also Indicated Preoperatively, And Sometimes Postoperatively, To Prevent Or Attenuate The Development Of Clinical And Laboratory Signs Of Malignant Hyperthermia In Individuals Judged To Be Malignant Hyperthermia Susceptible.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Dantrolene Sodium DANTROLENE SODIUM ZINC2568036

Comments